
Your Feed
Personalizing Myeloma Care | Chukwuemeka Uzoka, MD | Chicago RT
Pain Management and Real World Research | Karen Sweiss, PharmD | Chicago RT #myeloma
Audience Q&A with Faculty | Chicago RT
Past, Present & Your Path Forward | Morie Gertz, MD | Chicago RT #myeloma
CAR-T Therapy in 2025 | Meera Mohan, MD | Chicago RT #myeloma
The Ever Growing Bispecific Antibody Landscape | Attaya Suvannasankha, MD | Chicago RT #myeloma
How to Thrive With Community or Academic Center Myeloma Care | Tulio Rodriguez, MD | Chicago RT
What is the goal of risk stratification in smoldering myeloma? What is the IMWG risk model for SMM? In addition to the variables used to calculate risk in the IMWG model, other factors might be considered when stratifying for HRSMM?
What long-term strategies should myeloma patients understand?








